Pojo M - Search Results

1

PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness.

Brito C, Tomás A, Azevedo A, Esteves S, Mafra M, Roque L, Pojo M. Brito C, et al. Among authors: pojo m. Clin Med Insights Oncol. 2022 Jan 6;16:11795549211068804. doi: 10.1177/11795549211068804. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35023985 Free PMC article.

2

Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.

Pinto AT, Pojo M, Simões-Pereira J, Roque R, Saramago A, Roque L, Martins C, André S, Cabeçadas J, Leite V, Cavaco BM. Pinto AT, et al. Among authors: pojo m. Endocrine. 2019 Nov;66(2):288-300. doi: 10.1007/s12020-019-02009-5. Epub 2019 Jul 31. Endocrine. 2019. PMID: 31368081

3

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.

Brito C, Azevedo A, Esteves S, Marques AR, Martins C, Costa I, Mafra M, Bravo Marques JM, Roque L, Pojo M. Brito C, et al. Among authors: pojo m. BMC Cancer. 2019 Oct 17;19(1):968. doi: 10.1186/s12885-019-6177-0. BMC Cancer. 2019. PMID: 31623593 Free PMC article.

4

Melanoma Metabolism: Cell Survival and Resistance to Therapy.

Luís R, Brito C, Pojo M. Luís R, et al. Among authors: pojo m. Adv Exp Med Biol. 2020;1219:203-223. doi: 10.1007/978-3-030-34025-4_11. Adv Exp Med Biol. 2020. PMID: 32130701 Review.

5

High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma.

Campos C, Fragoso S, Luís R, Pinto F, Brito C, Esteves S, Pataco M, Santos S, Machado P, Vicente JB, Rosa JC, Cavaco BM, Moura C, Pojo M. Campos C, et al. Among authors: pojo m. Genes (Basel). 2020 Apr 8;11(4):403. doi: 10.3390/genes11040403. Genes (Basel). 2020. PMID: 32276436 Free PMC article.

6

Subversion of Ras Small GTPases in Cutaneous Melanoma Aggressiveness.

Brito C, Barral DC, Pojo M. Brito C, et al. Among authors: pojo m. Front Cell Dev Biol. 2020 Sep 23;8:575223. doi: 10.3389/fcell.2020.575223. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33072757 Free PMC article. Review.

7

The Impact of Olive Oil Compounds on the Metabolic Reprogramming of Cutaneous Melanoma Cell Models.

Brito C, Tomás A, Silva S, Bronze MR, Serra AT, Pojo M. Brito C, et al. Among authors: pojo m. Molecules. 2021 Jan 8;26(2):289. doi: 10.3390/molecules26020289. Molecules. 2021. PMID: 33430068 Free PMC article.

8

Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis.

Brito C, Costa-Silva B, Barral DC, Pojo M. Brito C, et al. Among authors: pojo m. Int J Mol Sci. 2021 Aug 26;22(17):9260. doi: 10.3390/ijms22179260. Int J Mol Sci. 2021. PMID: 34502169 Free PMC article.

9

The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness.

Cabaço LC, Tomás A, Pojo M, Barral DC. Cabaço LC, et al. Among authors: pojo m. Front Oncol. 2022 May 10;12:887366. doi: 10.3389/fonc.2022.887366. eCollection 2022. Front Oncol. 2022. PMID: 35619912 Free PMC article. Review.

10

Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Martins EP, Gonçalves CS, Pojo M, Carvalho R, Ribeiro AS, Miranda-Gonçalves V, Taipa R, Pardal F, Pinto AA, Custódia C, Faria CC, Baltazar F, Sousa N, Paredes J, Costa BM. Martins EP, et al. Among authors: pojo m. Mol Oncol. 2022 Jul;16(14):2611-2631. doi: 10.1002/1878-0261.13162. Epub 2022 Jun 10. Mol Oncol. 2022. PMID: 34919784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters